Claes G Trope
Overview
Explore the profile of Claes G Trope including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
124
Citations
3328
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Agostini A, Brunetti M, Davidson B, Trope C, Heim S, Panagopoulos I, et al.
Oncotarget
. 2016 Nov;
7(51):85058-85062.
PMID: 27835588
Malignant tumors of the vulva, most of them squamous cell carcinomas, account for only 5% of cancers of the female genital tract. Though little is known about the genetic features...
12.
Broner E, Trope C, Reich R, Davidson B
Hum Pathol
. 2016 Nov;
60:180-187.
PMID: 27825812
The objective of this study was to analyze the expression and clinical role of molecules involved in exosome synthesis and secretion in high-grade serous carcinoma, with focus on malignant effusions....
13.
Yu D, Holm R, Goscinski M, Trope C, Nesland J, Suo Z
Am J Cancer Res
. 2016 Oct;
6(9):2088-2097.
PMID: 27725913
Ovarian cancer is the most lethal gynecologic malignancy, in which cancer stem cells (CSC) have been reported to be the driving force of relapse and therapy-resistance. It is therefore important...
14.
Li Y, Huang R, Li X, Li X, Yu D, Zhang M, et al.
Am J Cancer Res
. 2016 Oct;
6(9):2076-2087.
PMID: 27725912
Pyruvate dehydrogenase A1 (PDHA1) serves as a gate-keeper enzyme link between glycolysis and the mitochondrial citric acid cycle. The inhibition of PDHA1 in cancer cells can result in an increased...
15.
Horwitz V, Davidson B, Stern D, Trope C, Tavor Reem T, Reich R
PLoS One
. 2016 Sep;
11(9):e0162502.
PMID: 27622508
Objective: Ezrin and p130Cas are structural proteins with an important role in signaling pathways and have been shown to promote cancer dissemination. We previously reported on overexpression of both ezrin...
16.
Nymoen D, Slipicevic A, Holth A, Emilsen E, Falkenthal T, Trope C, et al.
Hum Pathol
. 2016 Apr;
54:74-81.
PMID: 27063471
The objective of this study was to analyze the clinical role of 9 microRNAs (miRs) previously found to be overexpressed in ovarian carcinoma effusions compared with primary ovarian carcinomas. High-grade...
17.
Makar A, Trope C, Tummers P, Denys H, Vandecasteele K
Oncologist
. 2016 Mar;
21(6):745-54.
PMID: 27009938
Background: Standard treatment of stage III and IV advanced ovarian cancer (AOC) consists of primary debulking surgery (PDS) followed by chemotherapy. Since the publication of the European Organisation for Research...
18.
Li X, Huang R, Li R, Trope C, Nesland J, Suo Z
Mol Clin Oncol
. 2016 Feb;
4(1):18-22.
PMID: 26870350
A growing body of evidence indicates that aberrant activation of epithelial-to-mesenchymal transition (EMT) plays a key role in tumor cell invasion and metastasis. Zinc finger E-box-binding homeobox factor 1 (ZEB1),...
19.
Davidson B, Holth A, Hellesylt E, Hadar R, Katz B, Trope C, et al.
Hum Pathol
. 2015 Dec;
48:95-101.
PMID: 26640230
The objective of this study was to analyze the expression and clinical role of the RNA-binding molecule HuR in metastatic high-grade ovarian serous carcinoma (HGSC). HUR mRNA expression by reverse-transcription...
20.
Bartlett T, Jones A, Goode E, Fridley B, Cunningham J, Berns E, et al.
PLoS One
. 2015 Dec;
10(12):e0143178.
PMID: 26629914
We introduce a novel per-gene measure of intra-gene DNA methylation variability (IGV) based on the Illumina Infinium HumanMethylation450 platform, which is prognostic independently of well-known predictors of clinical outcome. Using...